Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Return on Assets [ROA] (2021 - 2026)

Updated

Vor Biopharma (VOR) reported Return on Assets [ROA] of -33.10% for Q3 2026, up 157.32 percentage points from -190.42% a year earlier but down 5.91 percentage points from the prior quarter.

Analysis

Vor Biopharma (VOR) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Vor Biopharma posted Return on Assets [ROA] of -120.52%, down 51.95 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, with a four-year change of -77.25 percentage points (FY2021 to FY2025).
  • By year, Return on Assets [ROA] came in at -68.57% in FY2024 (-21.18 pp), -47.38% in FY2023 (-13.40 pp), -33.99% in FY2022 (+9.28 pp) and -43.26% in FY2021.
  • Five-year quarterly Return on Assets [ROA] spans a low of -231.66% in Q2 2025 and a high of -27.19% in Q2 2026.
  • Year over year, Return on Assets [ROA] has now increased in each of the last three quarters, with an average year-over-year change of +4.51 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 204.48 percentage points); the low point was Q2 2025 (a drop of 155.13 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -27.19% (Q2 2026), -75.09% (Q1 2026) and -114.24% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Vor Biopharma 1.20 Bn -692.85 Mn - 276.64%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 276.64%
Jun 30, 2026 126.92%
Mar 31, 2026 -182.06%
Dec 31, 2025 -217.36%
Sep 30, 2025 -1,283.83%
Jun 30, 2025 -1,057.79%
Mar 31, 2025 -93.96%
Dec 31, 2024 -90.25%
Sep 30, 2024 -87.05%
Jun 30, 2024 -76.29%
Mar 31, 2024 -65.81%
Dec 31, 2023 -55.64%
Sep 30, 2023 -48.36%
Jun 30, 2023 -39.82%
Mar 31, 2023 -33.59%
Dec 31, 2022 -36.72%
Sep 30, 2022 -40.66%
Jun 30, 2022 -35.97%
Mar 31, 2022 -33.13%
Dec 31, 2021 -27.49%
API Access

Vor Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY